For research and educational purposes only. Not medical advice.
CDP-Choline Reference
Educational, not medical advice reference for CDP-Choline: Nootropic, Cognitive; regulatory status, evidence posture, source review, and schedule notes. Also…
Reference summary
Stroke-recovery trials and cognitive-impairment literature exist in non-US markets. Larger meta-analyses report mixed but generally positive effects.
- Categories
- Nootropic, Cognitive
- Aliases
- Citicoline, Cognizin, Ceraxon
- Evidence posture
- human — Sold as a dietary supplement in the US, not as an FDA-approved drug. Approved in non-US markets for stroke / cognitive impairment.
- Regulatory status
- No FDA-approved citicoline drug label in the US. Approved in Japan, Italy, and many other non-US markets for stroke and cognitive impairment. Sold as a dietary supplement (Cognizin) in the US.
- Content review status
- research reference